According to the research team, the relevance of their findings to human disease was validated
using chondrocytes isolated from arthritic patients.
Not exact matches
Using chondroitin sulfate to improve the viability and biosynthesis of
chondrocytes encapsulated in interpenetrating network (IPN) hydrogels of agarose and poly (ethylene glycol) diacrylate.
In an attempt to bring patient - specific induced pluripotent stem cell (iPSCs) technology closer to the clinic, researchers have created iPSCs from patient - derived
chondrocytes,
using an non-integrative reprogramming method, and
used these to then create large numbers of cartilage producing cells.
Based on previous protocols [5, 6] they have now created a 3D protocol for chondrogenic lineage differentiation via the generation of a putative chondrogenic progenitor cell population, and have found that
using this protocol C - iPSCs can be readily differentiated into cartilage in a manner comparable to that of mature
chondrocytes [7].
Even the authors of the esteemed Small Animal Surgery textbook assert, «Most NSAIDs interfere with
chondrocyte (cartilage cells) glycosaminoglycan synthesis and therefore should be
used continuously only for a short time.»